# Dr. Kamil Tamiola > Dr. Kamil Tamiola is Chief Executive Officer at Peptone. [View this page on Peptone](https://peptone.io/about/team/kamil-tamiola/) ## Role Chief Executive Officer Groups: board, leadership Dr. Kamil Tamiola is the founder and Chief Executive Officer of Peptone and serves on its Board of Directors. A physicist by training, he was drawn to intrinsically disordered proteins by Prof. Sir Christopher Dobson’s work at St John’s College, Cambridge. He completed the Top Master programme in Biomolecular Sciences at the University of Groningen, earning an MSc and PhD in applied NMR spectroscopy of disordered proteins. He later worked at the intersection of spectroscopy, molecular dynamics, biomolecular simulation, and intrinsically disordered protein biology before founding Peptone to unite experimental biophysics, statistical physics, high-performance computing, and machine learning. Under his leadership, Peptone raised a $40 million Series A and expanded experimental operations in Bellinzona, Switzerland. The company couples measurements of dynamic proteins with computation, then returns predictions to the laboratory for testing. Kamil serves on the ELIXIR CZ Scientific Advisory Board and the Swiss Economic Forum SME Parliament. Before Peptone, he worked in academic research and supercomputing. He also completed professional undergraduate training in music, specializing in Baroque repertoire and performance, a discipline that continues to shape how he works. Outside biotechnology, he practised alpine and outdoor photography professionally, with work featured by *National Geographic*, *Outside*, and other international publications. His leadership reflects the same emphasis on preparation, interdisciplinarity, and evidence. ## Selected sources ### [Inside Peptone: A Conversation with Kamil Tamiola and Hussein Kanji](https://www.youtube.com/watch?v=wcSPRh_1r6s) - Publisher: Taplow Blue Capital - Source type: Video interview A third of the proteins in the human body are "disordered" - too complex to study, and long ignored by science. Zero drugs target them. That's exactly where Peptone is looking for its breakthrough. We visit the lab in Bellinzona to meet founder-CEO Kamil and executive chairman and investor Hussein - one of the first believers in Peptone. They tell the non-linear story of how Peptone got here - from a vague scientific idea to a repeatable drug discovery foundry now pointed at multiple targets, from prostate cancer to neurodegeneration. A conversation about disordered proteins, the real role of AI in drug discovery, bold bets, and building something no one knows will work until it does. ### [ELIXIR CZ Scientific Advisory Board](https://www.elixir-czech.cz/about-elixir-cz/governance) - Publisher: ELIXIR CZ - Source type: Public service ELIXIR CZ lists Kamil as a member of its Scientific Advisory Board, providing independent guidance on the infrastructure’s scientific objectives and long-term strategy. ### [SME Parliament 2025](https://www.swisseconomic.ch/en/kmu-parlament) - Publisher: Swiss Economic Forum - Source type: Public service Kamil serves as a member of the SME Parliament, contributing an entrepreneur’s perspective to economic-policy discussion. ### [Founder spotlight: Kamil Tamiola, Peptone](https://hoxtonventures.com/founder-spotlight-kamil-tamiola-peptone/) - Publisher: Hoxton Ventures - Source type: Investor profile Kamil reflects on founding Peptone, GPU-accelerated supercomputing, uncertainty, and the work of building a company. ### [Behind the Breakthrough: Q&A with Peptone, Kamil Tamiola](https://fprimecapital.com/blog/behind-the-breakthrough-qa-with-peptone-kamil-tamiola/) - Publisher: F-Prime Capital - Source type: Investor profile Kamil discusses interdisciplinary science, disordered proteins, leadership, mentors, and the habits that support his work. ### [Peptone: finding opportunity in disorder](https://www.nature.com/articles/d41587-023-00011-x) - Publisher: Nature Biotechnology - Source type: Scientific profile A scientific profile of Peptone’s experimental and computational approach to intrinsically disordered proteins. ### [Founder Spotlight: Kamil Tamiola CEO & Founder of Peptone](https://waldencatalyst.com/blog/founder-spotlight-kamil-tamiola-ceo-and-founder-of-peptone) - Publisher: Walden Catalyst - Source type: Investor profile A conversation about Peptone’s mission, its 2022 Series A, sustainable computing, and Kamil’s work beyond the laboratory. ### [Peptone, a startup using A.I. to find drugs for tricky ‘disordered’ proteins, raises $40 million in venture funding](https://fortune.com/2022/06/09/peptone-disordered-proteins-venture-capital-funding-40-million/) - Publisher: Fortune - Source type: Media coverage Independent coverage of Peptone’s Series A, its work on disordered proteins, and the planned expansion in Bellinzona.